4.5 Article

Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast

Journal

MOLECULAR CANCER RESEARCH
Volume 17, Issue 7, Pages 1556-1570

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-19-0165

Keywords

-

Funding

  1. Department of Defense [DOD-W81XWH-15-1-0707]
  2. Susan G. Komen for the Cure [SAC110025]
  3. 100 Voices of Hope
  4. Susan G. Komen for the Cure
  5. Breast Cancer Research Foundation
  6. Vera Bradley Foundation for Breast Cancer Research
  7. Catherine Peachey Fund
  8. [R03CA195250-01A1]

Ask authors/readers for more resources

Functional modeling of normal breast epithelial hierarchy and stromal-epithelial cell interactions have been difficult due to inability to obtain sufficient stem-progenitor-mature epithelial and stromal cells. Recently reported epithelial reprogramming assay has partially overcome this limitation, but cross-contamination of cells from the feeder layer is a concern. The purpose of this study was to develop a feeder-layer-independent and inexpensive method to propagate multiple cell types from limited tissue resources. Cells obtained after enzymatic digestion of tissues collected at surgery or by core-needle biopsies were plated on tissue culture dishes precoated with laminin-5-rich-conditioned media from the rat bladder tumor cell line 804G and a defined growth media with inhibitors of ROCK, TGF beta, and BMP signaling. Cells were characterized by flow cytometry, mammosphere assay, 3D cultures, and xenograft studies. Cells from the healthy breasts included CD10(+)/EpCAM(-) basal/myoepithelial, CD49f(+)/EpCAM(+) luminal progenitor, CD49f(-)/EpCAM mature luminal, CD73(+)/EpCAM(+)/CD90(-) rare endogenous pluripotent somatic stem, CD73(+)/CD90(+)/EpCAM(-), estrogen receptor alpha-expressing ALCAM (CD166)(+)/EpCAM(+), and ALDFLUOR(+) stem/luminal progenitor subpopulations. Epithelial cells were luminal (KRT19(+)), basal (KRT14(+)), or dual-positive luminal/basal hybrid cells. While breast cells derived from BRCA1, BRCA2, and PALB2 mutation carriers did not display unique characteristics, cells from women with breast cancer-protective alleles showed enhanced differentiation. Cells could also be propagated from primary tumors and metastasis of breast, ovarian, and pancreatic cancerneuroendocrine subtype. Xenograft studies confirmed tumorigenic properties of tumor-derived cells. Implications: Our method expands the scope of individualized studies of patient-derived cells and provides resources to model epithelial-stromal interactions under normal and pathologic conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available